Democrats avoided infighting during a hearing on prescription drug prices Wednesday, a positive sign for the passage of a bill recently introduced by House Speaker Nancy Pelosi.
The hearing, held by the Energy and Commerce Committee’s health panel, was intended to look at several different proposals that would let the government become more involved in setting drug prices, but the Pelosi bill is the one House leaders intend to bring to the floor by the end of October.
Stay informed.Stay ahead.
Join Washington Examiner for unlimited access to the news, analysis, and commentary that matter most.
See Options
Already a member? Log in
Already a print subscriber? Click here to login/register your account
